chr6-36136734-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The ENST00000211287.9(MAPK13):c.574G>A(p.Glu192Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000929 in 1,613,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000211287.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAPK13 | NM_002754.5 | c.574G>A | p.Glu192Lys | missense_variant | 7/12 | ENST00000211287.9 | NP_002745.1 | |
MAPK13 | NR_072996.2 | n.644G>A | non_coding_transcript_exon_variant | 7/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAPK13 | ENST00000211287.9 | c.574G>A | p.Glu192Lys | missense_variant | 7/12 | 1 | NM_002754.5 | ENSP00000211287 | P1 | |
MAPK13 | ENST00000373766.9 | c.574G>A | p.Glu192Lys | missense_variant | 7/10 | 1 | ENSP00000362871 | |||
MAPK13 | ENST00000373759.1 | c.340G>A | p.Glu114Lys | missense_variant | 7/8 | 5 | ENSP00000362864 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250732Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135574
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461680Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 727130
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2022 | The c.574G>A (p.E192K) alteration is located in exon 7 (coding exon 7) of the MAPK13 gene. This alteration results from a G to A substitution at nucleotide position 574, causing the glutamic acid (E) at amino acid position 192 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at